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Leptomeningeal metastasis (LM) is caused by the spread of malignant tumor cells into the subarachnoid space. However, classi-
fication and staging of LM in the spinal canal is rare in the literature. The authors reviewed the records of 58 Chinese patients 
with LM for clinical features, neuroimaging, and treatments. Gadolinium-enhanced magnetic resonance imaging (MRI) of brain 
and spinal cord were performed in all patients. Removal of intracranial tumors was performed in all patients and diagnoses were 
confirmed by histology. The study group consisted of 58 patients, with 29 cases presenting with intraspinal symptoms. Of the 58, 
8 patients underwent intraspinal tumor removal, 8 received radiotherapy alone, 9 received chemotherapy alone, and 34 patients 
received combined radiochemotherapy. We classified LM into 3 types: type L or leptomeninges LM, is subdivided into 2 subtypes 
(subtype LI and LII (a,b)), type N or nerve root LM is subdivided into 2 subtypes (subtype NI and NII (a,b)), and type M or 
mixed-type LM. We also divided LM into stages of I–IV according to the symptoms and the volume of the tumor based on spinal 
axial MRI. Type LI LM often occurs in patients with intracranial and intraspinal tumors found simultaneously. Patients who re-
ceive surgery for intracranial tumors may present with type N LM. Surgery is suitable for patients with NI LM and LIIb LM in 
stages III–IV, presenting with severe spinal symptoms. The prognosis is better for type N LM than type L LM.  
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Leptomeningeal metastasis (LM) is caused by the spread of 
malignant tumor cells into the subarachnoid space. LM was 
observed in 5%–10% of patients with solid tumors, 5%– 
15% of patients with hematologic malignancies, and less 
than 2% of patients with primary brain tumors [1–3]. Some 
primary brain tumors, such as medulloblastoma and primary 
central nervous system lymphoma (PCNSL), have an inci-
dence of LM as high as 40% [4]. Previous classifications 
and staging for the neuraxis metastasis, such as the system 
used by Kelly et al. [5], classified the neuraxis dissemina-
tion of glioma into 4 types according to physiopathologic 
mechanisms and MRI features. Schiff and O’Neill [6] graded 
intramedullary metastasis into grades of 0–III according to 
the patient’s ability to ambulate at the time of diagnosis. 
However, literatures regarding classification or staging of 
LM in the spinal canal are rare. 
1  Materials and methods    
Clinical findings from 58 Chinese LM patients were studied 
retrospectively (Table S1), including spinal symptoms and 
signs. Whole brain and spinal cord MRI scans were per-
formed in all cases. Removal of intracranial tumors was 
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performed in all patients and diagnoses were confirmed by 
histology. Of the 58 cases, there were 23 medulloblastomas, 
3 primitive neuroectodermal tumors (PNET), 6 germinomas, 
2 mixed germ cell tumors, 1 immature teratoma, 4 glioblas-
tomas, 3 astrocytomas, 2 ependymomas, 3 anaplastic epen-
dymomas, 4 pineal parenchymal tumors of intermediate 
differentiation (PPTID), 1 pinealoblastoma (PB), 2 esthesio-
neuroblastomas, 1 anaplastic meningioma, 1 pituitary ade-
noma, 1 choroid plexus papilloma (CPP) and 1 PCNSL. 
According to growth patterns of the tumors using MRI, 
we classified LM into 3 types: type L or leptomeninges type, 
type N or nerve root type, and type M or mixed-type LM.   
Type L occurs when tumor cells grow on the surface of 
the leptomeninges and is subdivided into 2 subtypes: sub-
type LI and subtype LII. LI LM occurs when tumor cells 
disseminate on the leptomeninges in a miliary or linear pat-
tern without masses in the subarachnoid space. LII LM oc-
curs when tumor cells grow in the procumbent mode. LII 
LM is further divided into 2 subtypes, LIIa and LIIb ac-
cording to the different growth patterns. LIIa is defined as 
metastatic foci with an extensive distribution, while LIIb is 
considered to have a limited distribution (Figure 1).  
Type N is considered to be the most metastases with 
more than one lesion developing in the spinal nerves, most 
frequently in the cauda equina. Type N is further divided 
into 2 subtypes, NI and NII. NI LM tumors grow in a nodu-
lar mode, and NII tumors are large volume tumors with a 
diameter greater than the height of 2 vertebral bodies. There 
are also two NII growth patterns. In NIIa tumors, the meta-
static foci have irregular borders, and with NIIb the borders 
are distinct (Figure 2).  
Type M, or mixed-type LM, we define as occurring when 
LII LM and N LM exist simultaneously (Figure 3).  
We divided LM into 4 stages according to the symptoms 
and the volume of the tumor based on the spinal axial MRI. 
Stage I, also named as miliary LM, occurs when there are  
 
Figure 1  MRI of type LM L. (a) LI LM (case 22) MRI shows lep-
tomeningeal linear enhancement with diffuse miliary metastases; (b) LIIa 
LM (case 24) MRI shows cervical and thoracic leptomeningeal thickening 
and enhancement with extensive distribution; (c) LIIa LM (case 26) MRI 
shows complete leptomeningeal thickening and enhancement; (d) LIIa LM 
(case 36) MRI shows complete leptomeningeal thickening and enhance-
ment with metastatic foci filling almost the entire spinal canal; (e) LIIb LM 
(case 15) MRI shows a mass with a narrow base in the subarachnoid space 
at the level of C5–7. The growth pattern of the tumor is similar to spinal 
meningioma.  
 
Figure 2  MRI of type LM N. (a) NI LM (case 27) showing multiple 
round, nodular metastases in the cauda equine; (b) NI LM (case 28) show-
ing multiple round, nodular metastases in the cauda equine; (c) NI LM 
(case 54) showing a cylindrical metastasis in the cauda equine; (d) NIIb 
LM (case 30) showing the tumor filling the entire sacral canal with distinct 
borders; (e) NIIa LM (case 56) showing a giant metastasis filling the entire 
lumbar and sacral canal with irregular borders.     
 
Figure 3  MRI of type M or mixed-type. (a) MRI for case 44 showing the 
thoracic segment containing a wide-based, procumbent LM (LIIa) growing 
in a creeping fashion; (b) round, nodular metastasis in the cauda equine; (c) 
MRI for case 46 showing that the T1–4 segments contain a limited-base, 
procumbent LM (LIIa); (d) T10–12 segments contain a procumbent LM 
(LIIa), and a giant metastasis in the cauda equina.  
no intraspinal symptoms or impact on the spinal cord and 
spinal nerves. In stage II, the largest area of the tumors is 
less than 25% of the vertebral canal in the same section 
plane in the spinal axial MRI. In this stage, the tumor con-
tacts or presses on the spinal cord or spinal nerves, and pa-
tients have no or mild intraspinal symptoms. In stage III, the 
largest area of the tumors is 25%–75% of the vertebral canal 
in the same section plane in the axial MRI. In this stage, 
patients suffer from intraspinal symptoms. In stage IV, the 
largest area of the tumors is greater than 75% of the verte-
bral canal in the same section plane of the axial MRI. In this 
stage, the spinal cord and spinal nerves are severely com-
pressed, and serious intraspinal symptoms and paraplegia 
may occur (Figure 4).  
2  Results 
There were 42 males and 16 females in this group, with ages  
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Figure 4  (a) Stage I, also called miliary LM; (b) stage II, showing the largest area of the tumors is less than 25% of the vertebral canal in the same section plane 
in the axial MRI; (c) stage III, showing the largest area of the tumors is less than 75% but greater than 25% of the vertebral canal in the same section plane in the 
axial MRI; (d) stage IV, showing the largest area of the tumors is greater than 75% of the vertebral canal in the same section plane in the axial MRI. 
ranging from 2 to 71 years (average age 22.3 years). Intra-
cranial tumors and spinal drop metastases were found sim-
ultaneously in 19 cases, spinal metastases after intracranial 
tumor removal were found in 39 cases from 1 to 144 
months (average 32.0 months), and 29 cases presented with 
intraspinal symptoms.  
Thirty-two cases of type L were found, and 23 cases 
were LI LM. In 12 cases of LI LM intracranial and in-
traspinal tumors were found simultaneously, accounting for 
52.2% (12/23) of all LI cases. Patients who had previous 
intracranial tumor surgery were more likely to present with 
type N. There were 24 cases of type N in our 58 LM pa-
tients, and 21 cases of those occurred postoperatively, ac-
counting for 87.5% (21/24) of type N (Table 1).  
In our patient group, 25 cases were in stage I, 5 were in 
stage II, 15 were in stage III and 13 were in stage IV. The 
symptoms and signs were different between intramedullary 
and subdural spinal canal lesions. Apart from 5 cases of 
intramedullary metastases, in the remaining 53 cases, the 
incidence of the intraspinal symptoms and signs was 13% 
(3/23) in stage I, 25% (1/4) in stage II, 80% (12/15) in stage 
III and 81.8% (9/11) in stage IV. 
Surgeries for intracranial tumor were performed in all 
patients and, as the adjunctive therapy, 8 patients had radi-
otherapy alone, 9 patients had chemotherapy alone, and 34 
patients had combined radiochemotherapy. Seven patients 
had no any further therapy. Only 8 patients had surgery for 
intraspinal tumors. 
All the patients were followed up postoperatively from  
Table 1  LM classification in the patient group 
Type Subtype Growth features 
Number 
(case) 
L LI Miliary or/and linear 23 
 LIIa Procumbent with extensive territory 8 
 LIIb Procumbent with limited territory 1 
N NI Nodular 19 
 NIIa Giant with irregular boundary 4 
 NIIb Giant with distinct boundary 1 
M LII and N Procumbent and nodular or giant  2 
0.5 to 153 months (average 26.6 months). Twenty-one pa-
tients died, 11 patients worsened, 13 patients stabilized, and 
13 patients improved.  
3  Discussion and conclusions 
There are two main paths for CNS tumors to disseminate 
along the neuraxis. One path is direct extension arising from 
CNS tumors in close proximity to the leptomeninges or ep-
endyma [4]. This occurs with medulloblastoma, ependymoma, 
germinoma, and pineal parenchymal tumors [7], or gliomas 
contiguous with the ventricular system [8]. Deciduous tu-
mor cells travel through and then disseminate into the CSF 
when parenchymal tumors break through the leptomeninges 
or ependyma. The average interval between diagnosis of the 
primary brain tumor and diagnosis of CSF dissemination 
ranged from 5 to 14 months [9]. In two series, 33%–75% of 
patients with LM had synchronous intraparenchymal brain 
metastases [10,11]. This occurred in 32.8% (19/58) of the 
patients in our group. The volume of the metastatic foci 
from direct dissemination is usually very little, the foci be-
ing only slightly affected by gravity. Metastatic foci can 
float slowly through the CSF and grow throughout the sub-
arachnoid space.  
Another path of leptomeningeal dissemination is iatro-
genic spread into the CSF during surgery for parenchymal 
tumors [12,13]. Mahajan et al. [14] pointed out that the in-
cidence of LM was high if surgery was performed, and in 
our group the level was 67.2% (39/58). LM is particularly 
associated with parenchymal brain tumors located in the 
posterior fossa. Kitaoka et al. [15] suggested that cerebellar 
tumors have a higher risk than other intracranial tumors for 
CSF dissemination because of the proximity of the cerebel-
lar cisterns to the subarachnoid space. In our group 62.8% 
(22/32) of the tumors were in the posterior fossa, and the 
cauda equina remained the main site of dissemination [16]. 
Lumbar puncture and shunting procedures may also be fac-
tors in dissemination of the tumor via the CSF pathway. 
Continuous CSF drainage allowed the deciduous malignant 
cells to accumulate in the cauda equina. A high number of 
tumor cells or masses could fall into the subarachnoid spac-
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es during surgery and, usually, the volume of the metastatic 
foci is larger than the miliary foci, and these sink into the 
terminal cistern because of gravity.  
According to the classification of LM from CNS tumors, 
Zulch [17] grouped the spread of gliomas into 2 categories: 
multifocal and multicentric. Gururangan et al. [18] catego-
rized pontine glioma with neuraxis spread as parenchymal 
(PM), subependymal (SE), or leptomeningeal (LM) based 
on the location of LM on MRI. Kelly et al. [5] classified the 
neuraxis dissemination of glioma into leptomeningeal (type 
I), subependymal (type II), satellite (type IIIa, IIIb), and 
mixed (type IV) according to physiopathological mecha-
nisms and the MRI patterns of neuraxis dissemination. Saito 
et al. [19] classified the LM into a “diffuse type” of dissem-
ination with diffuse enhancement of the subarachnoid space 
on spinal MRI, a “nodular type” with a nodular tumor mass, 
and a “mixed type” with diffuse and nodular features. Three 
growth patterns of LM, thin diffuse coating of the meninges, 
plaque-like, and nodular deposits, were described by 
O’Meara et al. [20]. All classifications were based on a sin-
gle glioma with intracrainal metastases, and seldom con-
tained the characteristics of LM in the spinal canal. The 
diffuse type is the counterpart to type L, and the plaque-  
like form is a counterpart to type LII in our classification 
system.  
All CNS tumors can involve neuraxis metastasis [21–34] 
(Table 2); both malignant and benign tumors. To the best of 
our knowledge and search of the literatures, 58 cases of LM  
Table 2  Incidence of LM in different CNS tumors  
CNS tumor Incidence of LM 
Medulloblastoma 27%–43% [21]  
PCNSL 42% [22] 
Glioblastoma 15%–25% [23] 
Oligodendroglioma 14% [24] 
Ependymoma 13% [25] 
PB and PPTID 12.9% [26]  
Low grade astrocytoma 3.7%–5.3% [27] 
Germinoma 0–57% [28] 
Mixed germ cell tumor 4% [29] 
Meningioma 0.1% [30] 
Pituitary tumors Rare 57 cases [31] 
PRL 15 cases  
ACTH 13 cases 
GH 9 cases 
Nonfunctioning pituitary tumor 17 cases 
TSH 1 case 
FSH-LH 1 case 
Choroid plexus carcinoma Rare 11 cases [32,33]  
Esthesioneuroblastoma Rare 10 cases [34]  
involving 10 types of CNS tumors is the largest group at a 
single institution. In our group, there were larger numbers of 
medulloblastoma/PNET and these involved types LI, LII, NI, 
and NII LM. There were a smaller number of glioblastomas/ 
astrocytomas, germ cell tumors, ependymomas/ana-plastic 
ependymomas, and pineal parenchymal tumors which in-
volved both LI or LII, and NI or NII LM. Therefore, all 
types of CNS tumors have similar dissemination patterns 
and we included all CNS tumors together to classify the 
LM.  
LI LM is the early stage of LM and the most common 
type. The cancer cells breach the leptomeninges and reach 
the CSF while floating along CSF pathways where they 
settle and grow anywhere along the neuraxis in a diffuse 
and multifocal manner. Progression of LI LM can follow 4 
different pathways: (1) Stabilization as the LI type, with no 
change in the tiny metastatic foci. (2) Development from LI 
LM to LII LM, if the tiny metastatic foci grow and gather 
together to become plaque-like metastatic foci. The entire 
leptomeninges are gradually colonized by the tumor cells 
and LII LM grows in a creeping mode that is similar to the 
growth pattern of moss (procumbent). (3) Progression into 
NI LM when the tiny foci settle and grow into spinal nerves. 
The tiny deposits gradually grow into nodular metastatic 
foci. (4) Transition directly into NII LM where the decidu-
ous tumor cells continuously fall and accumulate in the ter-
minal cistern. Concurrently, the tumor cells grow uninter-
rupted and eventually the metastatic foci fill the whole 
lumbosacral canal. This mode of growth is similar to the 
formation of a coral reef. The formation process can be seen 
in MRIs with the developed mass seen at the bottom of the 
lumbosacral canal, developing mass in the middle, and the 
miliary tumor cells seen in the superior part of the lumbosa-
cral canal (Figure 5(d)).    
 
Figure 5  The process of formation of NIIa from LI LM. (a) Case 5 
showing miliary metastaic foci depositing in the cauda equine; (b) and (c) 
case 32 MRI of the same patient at different periods of time over 1.5 
months; (d) case 51 showing the miliary metastatic foci are forming into 
NII LM. In the MRI, the developed mass can be seen at the level of L4–S1, 
the developing mass can be seen at the level of L2–L3, and miliary tumor 
cells without a defined mass can be seen above the level of L2. 
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LII LM is a rare subtype of LM described in the previous 
literature [35]. LII LM has two growth patterns, one that 
covers an extensive expanse of territory and a second that 
has a limited growth pattern. In the extensive growth pattern, 
the metastatic foci may possess multiple growth centers 
which, in the terminal stage, could stretch and cover the 
entire leptomeninges with tumor cells. With the limited 
growth pattern, the metastatic foci grow from a single center 
and the focus is usually solitary in the leptomeninges. This 
limited pattern is similar to spinal meningioma with a broad 
base and tail sign.  
Type N of LM usually occurs following craniotomy. The 
tumor cells or masses fall into the subarachnoid space and 
the volume of the metastatic foci is usually larger than mil-
iary foci. The metastatic foci sink into the terminal cistern 
due to their large volume and the effects of gravity. NI LM 
may remain in the same stage, or the nodular metastatic foci 
can grow into giant metastatic foci. NII LM can develop 
from LI LM or NI LM and the difference is that those orig-
inating from LI LM have irregular boundaries (NIIa), while 
those arising from NI have distinct boundaries (NIIb) (Fig-
ures 5(d), 6(c)).  
Patients with LM should receive complete craniospinal 
MRI to properly determine the treatment strategy and assess 
the prognosis. Once the tumor involves any part of the lep-
tomeninges, the tumor cells could begin to spread through 
the CSF to the whole neuraxis. Thus, leptomeningeal me-
tastasis, although sometimes limited to few localized areas, 
is usually considered a diffuse disease of the CNS [36]. Pa-
tients with brain tumors are usually scanned with intracrani-
al MRI, and complete spinal MRI is not part of the routine  
 
Figure 6  MRI showing the formation of NIIb from NI LM. (a) (case 40) 
The nodular metastatic foci are very small; (b) (case 28) large nodular 
metastatic foci in the cauda equine; (c) (case 30) nodular metastatic mass 
growing uninterrupted into a giant mass in the sacral canal.  
examination. However, complete spinal MRI should be car-
ried out in the following situations: (1) Leptomeningeal focal, 
diffuse or nodular enhancements can be seen on the cerebral 
and cerebellar folia, basal cisterns, tentorium, and the ven-
tricular ependymal surface in the cranial MRI. (2) Patients 
present with symptoms and signs that cannot be explained 
by the intracranial tumors. (3) Patients suffer from brain 
tumors that are prone to disseminate through the CSF, such 
as medulloblastoma.  
Spinal surgeries are not suitable for subtypes LI LM as 
the metastases are tiny and multiple, and LIIa and NII LM 
as the metastasis is extensively distributed. Spinal surgeries 
are suitable for LIIb LM and NI LM because the metastases 
are localized. Eight cases received excision of intraspinal 
tumors in this group and all 8 cases were stages III–IV. The 
symptoms improved in 7 cases with NI, LIIb and M (NI 
mixed with LIIb) types. However, in 1 case of astrocytoma 
(case 1) LIIa subtype, spinal surgeries were performed 3 
times to remove all the spinal canal metastases. In this case, 
the prognosis was poor for spinal injury and instability of 
the vertebral column. Therefore, spinal surgery should not 
be performed if the metastasis is dispersed in LM, unless 
patients with NI and LIIb LM in stages III–IV present with 
severe symptoms related to spinal compression. Surgical 
intervention cannot remove all the intraspinal tumors. 
Therefore, chemotherapy and radiotherapy should be the 
major methods for systemic treatment. All types and stages 
LM were suitable for chemotherapy or/and radiotherapy if 
the tumors types were suitable for these therapies. Spinal 
imaging helps to determine the placement of the inferior 
field edge for spinal radiation [37].  
LM is the terminal stage of cancer, the prognosis for pa-
tients with LM is very poor, and untreated patients usually 
die within months. Median survival of treated patients is 
4–5 months but varies depending on primary tumor types 
[38]. The cause of death in patients with LM is meningeal 
(neurological) tumor progression (5%–87%), treatment- 
related toxicity (0–15%), or other non–neoplastic diseases 
(0–29%) [39]. The prognosis is related to the primary tumor, 
the location of the tumor, and the treatments involved. For 
example, germinomas have an optimistic prognosis as they 
are sensitive to chemotherapy and radiotherapy. There was 
only 1 case of death due to germinoma in our group. The 
survival rate is higher in type N LM than for type L LM. 
The reasons are that type N usually occurs in the cauda 
equina, an area that cannot produce lethal neurological dys-
function. Furthermore, type N LM is suitable for surgery. 
Saito et al. [19] reported one patient with nodular type gli-
oma who survived for 20 months after spinal dissemination. 
This type of dissemination may be more controllable with 
local intensive treatment. Type L diffuses not only into the 
spinal canal, but also into the entire neuraxis. In our 23 me-
dulloblastoma patients, 11 died, and among them, only 1 
was type N; the other 10 cases were type L.  
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